{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:13:28Z","timestamp":1788556408823,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X013189\/1"],"award-info":[{"award-number":["MR\/X013189\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013468\/1"],"award-info":[{"award-number":["MR\/N013468\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Z504725\/1"],"award-info":[{"award-number":["MR\/Z504725\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/X511353\/1"],"award-info":[{"award-number":["BB\/X511353\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["216593\/Z\/19\/Z"],"award-info":[{"award-number":["216593\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201726","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:23:32Z","timestamp":1774931012000},"page":"201726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7579-3469","authenticated-orcid":false,"given":"C\u00e9lia","family":"Sourd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly C.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martinez-Fernandez de la Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshanie C.","family":"Wickramasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Shamsnajafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calliope A.","family":"Dendrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Cehajic-Kapetanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-9131","authenticated-orcid":false,"given":"Kanmin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201726_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101354","article-title":"Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy","volume":"106","author":"Purdy","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2026.201726_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201726_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201726_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2\/3 Study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201726_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2024.11.021","article-title":"Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1\/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results","volume":"271","author":"Yang","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamaophthalmol.2019.3278","article-title":"Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical Trial","volume":"137","author":"Fischer","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/biom14010122","article-title":"Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study","volume":"14","author":"Fischer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.omta.2026.201726_bib8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/s41591-023-02520-3","article-title":"Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial","volume":"29","author":"MacLaren","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201726_bib9","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene Editing for CEP290-Associated Retinal Degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201726_bib10","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0140-6736(24)00310-6","article-title":"Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1\/2a dose-escalation study","volume":"403","author":"Campochiaro","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201726_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2022.06.018","article-title":"Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy","volume":"129","author":"Kessel","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201726_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(24)01447-8","article-title":"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1\/2, multicentre, open-label, unilateral dose escalation study","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201726_bib13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100516","article-title":"Dose-Dependent Progression of Chorioretinal Atrophy at the Injection Site After Subretinal Injection of rAAV2\/8 in Nonhuman Primates","volume":"4","author":"Seitz","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.omta.2026.201726_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","article-title":"Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina","volume":"22","author":"Chandler","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201726_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09273948.2015.1134581","article-title":"Adalimumab for Ocular Inflammation","volume":"25","author":"Durrani","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.omta.2026.201726_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41433-023-02725-3","article-title":"Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes","volume":"38","author":"Bober","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.omta.2026.201726_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41433-023-02800-9","article-title":"Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study","volume":"38","author":"\u00c7am","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.omta.2026.201726_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201726_bib20","first-page":"2815","article-title":"Retinal Pigment Epithelial Cell Distribution in Central Retina of Rhesus Monkeys","volume":"43","author":"Snodderly","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201726_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10633-019-09733-3","article-title":"Effects of DTL electrode position on the amplitude and implicit time of the electroretinogram","volume":"140","author":"Brouwer","year":"2020","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajo.2019.05.028","article-title":"Prolonged Cone b-Wave on Electroretinography Is Associated with Severity of Inflammation in Noninfectious Uveitis","volume":"207","author":"Brouwer","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9394(85)90351-4","article-title":"Natural course of retinitis pigmentosa over a three-year interval","volume":"99","author":"Berson","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib24","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","article-title":"Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations","volume":"25","author":"Beltran","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201726_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68401-y","article-title":"Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis","volume":"14","author":"Quinn","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201726_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/hum.2022.222","article-title":"The Degree of Adeno-Associated Virus-Induced Retinal Inflammation Varies Based on Serotype and Route of Delivery: Intravitreal, Subretinal, or Suprachoroidal","volume":"34","author":"Wiley","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201726_bib27","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201726_bib28","article-title":"Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration","author":"Hallam","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.omta.2026.201726_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamaophthalmol.2022.6254","article-title":"Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations","volume":"141","author":"von Krusenstiern","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omta.2026.201726_bib30","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1167\/iovs.11-7470","article-title":"Misexpression of the constitutive Rpgr(ex1-19) variant leads to severe photoreceptor degeneration","volume":"52","author":"Wright","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201726_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2019.297","article-title":"Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Retinitis Pigmentosa","volume":"31","author":"Dufour","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201726_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/hum.2019.337","article-title":"Dose Range Finding Studies with Two RPGR Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene Therapy","volume":"31","author":"Song","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201726_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2023.02.015","article-title":"Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy","volume":"130","author":"Stingl","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201726_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2019.08.011","article-title":"Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates","volume":"15","author":"Weed","year":"2019","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201726_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.omta.2026.201726_bib36","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41598-023-28830-7","article-title":"Extra-viral DNA in adeno-associated viral vector preparations induces TLR9-dependent innate immune responses in human plasmacytoid dendritic cells","volume":"13","author":"Bucher","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201726_bib37","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201726_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-014-0224-1","article-title":"Chemokine-mediated inflammation in the degenerating retina is coordinated by M\u00fcller cells, activated microglia, and retinal pigment epithelium","volume":"12","author":"Rutar","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.omta.2026.201726_bib39","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis-regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201726_bib40","article-title":"Epigenetic adaptation drives monocyte differentiation into microglia-like cells upon engraftment into the retina","author":"Liu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.omta.2026.201726_bib41","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1038\/s41467-023-40674-3","article-title":"Spatial organization of the mouse retina at single cell resolution by MERFISH","volume":"14","author":"Choi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201726_bib42","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41467-025-57625-9","article-title":"Spatiotemporally resolved transcriptomics reveals the cellular dynamics of human retinal development","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201726_bib43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.omta.2026.201726_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201726_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"GigaScience"},{"key":"10.1016\/j.omta.2026.201726_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.omta.2026.201726_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omta.2026.201726_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201726_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbac016","article-title":"decoupleR: ensemble of computational methods to infer biological activities from omics data","volume":"2","author":"Badia-I-Mompel","year":"2022","journal-title":"Bioinform. Adv."},{"key":"10.1016\/j.omta.2026.201726_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omta.2026.201726_bib51","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"Sergushichev","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.omta.2026.201726_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac746","article-title":"scFates: a scalable python package for advanced pseudotime and bifurcation analysis from single-cell data","volume":"39","author":"Faure","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201726_bib53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/spe.4380211102","article-title":"Graph drawing by force-directed placement","volume":"21","author":"Fruchterman","year":"1991","journal-title":"Software Pract. Ex."},{"key":"10.1016\/j.omta.2026.201726_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23477-2","article-title":"Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia","volume":"12","author":"Washer","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:29:46Z","timestamp":1788553786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000613"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201726","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.31.667874","asserted-by":"object"}]},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201726"}}